Clinical features and prognosis of ANCA-associated vasculitis patients who were double-seropositive for myeloperoxidase-ANCA and proteinase 3-ANCA

被引:0
|
作者
Gong, Yizi [1 ,2 ,3 ]
Shen, Chanjuan [4 ]
Meng, Ting [1 ]
Lin, Wei [5 ]
Hu, Xueling [1 ]
Tang, Rong [1 ]
Xiong, Qi [1 ]
Ooi, Joshua D. [1 ,6 ]
Eggenhuizen, Peter J. [6 ]
Chen, Jinbiao [7 ]
Zhou, Ya-Ou [8 ]
Luo, Hui [8 ]
Xu, Jia [1 ]
Liu, Ning [1 ]
Xiao, Ping [1 ]
Xiao, Xiangcheng [1 ,2 ,3 ]
Zhong, Yong [1 ,2 ,3 ]
机构
[1] Cent South Univ, Xiangya Hosp, Dept Nephrol, 87 Xiangya Rd, Changsha, Hunan, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Key Lab Biol, Nanotechnol Natl Hlth Commiss, Changsha, Hunan, Peoples R China
[3] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha 410008, Hunan, Peoples R China
[4] Cent South Univ, Affiliated Zhuzhou Hosp, Xiangya Med Coll, Dept Hematol, Zhuzhou, Peoples R China
[5] Cent South Univ, Xiangya Hosp, Dept Pathol, Changsha, Hunan, Peoples R China
[6] Monash Univ, Ctr Inflammatory Dis, Dept Med, Sch Clin Sci, Clayton, Vic, Australia
[7] Cent South Univ, Xiangya Hosp, Dept Med Records & Informat, Changsha, Hunan, Peoples R China
[8] Cent South Univ, Xiangya Hosp, Dept Rheumatol & Immunol, Changsha, Peoples R China
关键词
ANCA-associated vasculitis; Double-positive vasculitis; Myeloperoxidase; Proteinase; 3; Prognosis; RHEUMATOLOGY CLASSIFICATION CRITERIA; 2022; AMERICAN-COLLEGE; MICROSCOPIC POLYANGIITIS; RENAL SURVIVAL; GRANULOMATOSIS; ALLIANCE; RELAPSE; ANTIBODIES; OUTCOMES;
D O I
10.1007/s10238-024-01318-y
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) patients with dual positivity for proteinase 3-ANCA (PR3-ANCA) and myeloperoxidase-ANCA (MPO-ANCA) are uncommon. We aimed to investigate these idiopathic double-positive AAV patients' clinical features, histological characteristics, and prognosis. We reviewed all the electronic medical records of patients diagnosed with AAV to obtain clinical data and renal histological information from January 2010 to December 2020 in a large center in China. Patients were assigned to the MPO-AAV group or PR3-AAV group or idiopathic double-positive AAV group by ANCA specificity. We explored features of idiopathic double-positive AAV. Of the 340 patients who fulfilled the study inclusion criteria, 159 (46.76%) were female, with a mean age of 58.41 years at the time of AAV diagnosis. Similar to MPO-AAV, idiopathic double-positive AAV patients were older and had more severe anemia, lower Birmingham Vasculitis Activity Score (BVAS) and C-reactive protein (CRP) levels, less ear, nose, and throat (ENT) involvement, higher initial serum creatinine and a lower estimated glomerular filtration rate (eGFR) when compared with PR3-AAV (P < 0.05). The proportion of normal glomeruli of idiopathic double-positive AAV was the lowest among the three groups (P < 0.05). The idiopathic double-positive AAV patients had the worst remission rate (58.8%) among the three groups (P < 0.05). The relapse rate of double-positive AAV (40.0%) was comparable with PR3-AAV (44.8%) (P > 0.05). Although there was a trend toward a higher relapse rate of idiopathic double-positive AAV (40.0%) compared with MPO-AAV (23.5%), this did not reach statistical significance (P > 0.05). The proportion of patients who progressed to ESRD was 47.1% and 44.4% in the idiopathic double-positive AAV group and MPO-AAV group respectively, without statistical significance. Long-term patient survival also varied among the three groups (P < 0.05). Idiopathic double-positive AAV is a rare clinical entity with hybrid features of MPO-AAV and PR3-AAV. MPO-AAV is the "dominant" phenotype in idiopathic double-positive AAV.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Clinical features and prognosis of ANCA-associated vasculitis patients who were double-seropositive for myeloperoxidase-ANCA and proteinase 3-ANCA
    Yizi Gong
    Chanjuan Shen
    Ting Meng
    Wei Lin
    Xueling Hu
    Rong Tang
    Qi Xiong
    Joshua D. Ooi
    Peter J. Eggenhuizen
    Jinbiao Chen
    Ya-Ou Zhou
    Hui Luo
    Jia Xu
    Ning Liu
    Ping Xiao
    Xiangcheng Xiao
    Yong Zhong
    [J]. Clinical and Experimental Medicine, 24
  • [2] Proteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA Vasculitis
    Hilhorst, Marc
    van Paassen, Pieter
    Tervaert, Jan Willem Cohen
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 26 (10): : 2314 - 2327
  • [3] Renal Survival in Proteinase 3 and Myeloperoxidase ANCA-Associated Systemic Vasculitis
    de Joode, Anoek A. E.
    Sanders, Jan Stephan F.
    Stegeman, Coen A.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 8 (10): : 1709 - 1717
  • [4] Long-term treatment results and the immunoglobulin G subclass distribution patterns of proteinase-3-antineutrophil cytoplasm antibody (ANCA) and myeloperoxidase-ANCA in ANCA-associated vasculitis
    Almroth, Gabriel
    Berlin, Gosta
    Andersson, Bengt
    Hahn-Zoric, Mirjana
    [J]. SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2009, 43 (02): : 160 - 170
  • [5] Systematic Histological Scoring Reveals More Prominent Interstitial Inflammation in Myeloperoxidase-ANCA Compared to Proteinase 3-ANCA Glomerulonephritis
    Hakroush, Samy
    Kluge, Ingmar Alexander
    Stroebel, Philipp
    Korsten, Peter
    Tampe, Desiree
    Tampe, Bjorn
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (06) : 1 - 11
  • [6] Clinical features and prognosis of MPO-ANCA and anti-GBM double-seropositive patients
    Hu, Xueling
    Shen, Chanjuan
    Meng, Ting
    Ooi, Joshua D.
    Eggenhuizen, Peter J.
    Zhou, Ya-ou
    Luo, Hui
    Chen, Jin-biao
    Lin, Wei
    Gong, Yizi
    Xiong, Qi
    Xu, Jia
    Liu, Ning
    Xiao, Xiangcheng
    Tang, Rong
    Zhong, Yong
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [7] Differences in clinico-pathological characteristics and outcomes between proteinase 3-ANCA positivity and myeloperoxidase-ANCA positivity in lupus nephritis
    Li, C.
    Wang, J-J
    Zhou, M-L
    Liang, D-D
    Yang, J.
    Zhu, H-X
    Hu, W-X
    Zhang, H-T
    [J]. LUPUS, 2019, 28 (09) : 1111 - 1119
  • [8] Complement activation prior to symptom onset in myeloperoxidase ANCA-associated vasculitis but not proteinase 3 ANCA associated vasculitis-A Swedish biobank study
    Johansson, L.
    Berglin, E.
    Eriksson, O.
    Mohammad, A. J.
    Dahlqvist, J.
    Rantapaa-Dahlqvist, S.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2022, 51 (03) : 214 - 219
  • [9] CLINICAL FEATURES AND PROGNOSIS OF ANCA-ASSOCIATED VASCULITIS WITH RENAL INVOLVEMENT AT DIAGNOSIS
    Fukui, S.
    Iwamoto, N.
    Shimizu, T.
    Umeda, M.
    Nishino, A.
    Koga, T.
    Kawashiri, S. -Y.
    Hirai, Y.
    Ichinose, K.
    Tamal, M.
    Nakamura, H.
    Origuchi, T.
    Kawakami, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 318 - 319
  • [10] ANCA-associated vasculitis - clinical utility of using ANCA specificity to classify patients
    Cornec, Divi
    Cornec-Le Gall, Emilie
    Fervenza, Fernando C.
    Specks, Ulrich
    [J]. NATURE REVIEWS RHEUMATOLOGY, 2016, 12 (10) : 570 - 579